Revolutionizing Continuous Blood Pressure Monitoring with Motion-Correction Technology
Cambridge, MA. – December 3, 2024. Dynocardia has been awarded a $1 million grant by the National Science Foundation (NSF) to enhance its innovative computer vision-based motion-artifact mitigation technology.
Read the full press releaseDynocardia's Direct Continuous Blood Pressure Monitoring Technology Receives Grant from NIH's Commercialization Readiness Pilot Program
CAMBRIDGE, Mass., Oct. 10, 2024 /PRNewswire/ -- The National Heart, Lung, and Blood Institute (NHLBI) has awarded Dynocardia a $500,000 grant under its Commercial Readiness Pilot (CRP) Program.
Read the full press releaseJordan Parker-Ashe and Victoria Gonzalez-Canalle represented Dynocardia at the 2024 Engineering for Women's Health conference hosted by Northeastern University.
Our biomedical engineers represented Dynocardia at the 2024 Engineering for Women's Health conference. This experience was especially meaningful, as Dynocardia is conducting ongoing clinical trials involved in maternal health.